Records 1 - 3
| RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
Journal of translational medicine 2022 Sep 20 (1): 390.
Wang Chunyue, Zhang Zhenlong, Sun Yulan, Wang Song, Wu Mengmeng, Ou Qiuxiang, Xu Yang, Chen Zhiming, Shao Yang, Liu Hong, Hou Peife
| Identification of RET fusions in a Chinese multi-cancer retrospective analysis by next-generation sequencing.
Cancer science 2021 Oct .
Shi Minke, Wang Weiran, Zhang Jinku, Li Bobo, Lv Dongxiao, Wang Danhua, Wang Sizhen, Cheng Dezhi, Ma Tongh
| Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing.
Molecular oncology 2020 Sep .
Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho